Home VISUfarma

VISUfarma

acquired
-
Ophthalmic Drug Developer
Basic
Enterprise Profile

Basic Information

VISUfarma is a leading European specialty pharmaceutical company focused on ophthalmology. The integration of VISUfarma significantly expands Lupin's ophthalmology portfolio, covering more than 60 branded products in areas such as dry eye, glaucoma, eyelid hygiene, blepharitis, retinal health, and specialized nutraceuticals. VISUfarma has a strong commercial presence in key European markets, including Italy, the UK, Spain, Germany, and France, with a team possessing deep ophthalmic expertise, trusted relationships, and strong local market insights.
VISUfarma B.V
Amsterdam,NorthHolland,Netherlands
51~100 people
January 01, 2016
info@visufarma.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Concept
Ophthalmology Ocular Diseases Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs